Clinical Trials Logo

Filter by:
NCT ID: NCT06249477 Completed - Weight Loss Clinical Trials

Weight Loss and Physical Activity Lifestyle Interventions In Post Liver And Kidney Transplants

Start date: February 28, 2022
Phase: N/A
Study type: Interventional

This research project seeks to learn more about how lifestyle interventions can help liver and kidney transplant recipients achieve weight loss goals. The investigators want to evaluate if an intervention using weight and activity wrist monitors, as well as nutritional coaching group sessions is acceptable and useful for post-transplant patients aiming for weight loss. All participants will be given a wrist activity monitor, and a scale. Half of participants will be invited to participate in the nutritional coaching group sessions. The research team will look at weight loss, devices' usage, and satisfaction, and see if there are any difference among the two groups.

NCT ID: NCT06248788 Completed - Salivary Immunity Clinical Trials

Salivary Immunoglobulin A (sIgA) Normal Range Study

sIgA
Start date: June 19, 2017
Phase:
Study type: Observational

Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is available for consumers to purchase and test their own sIgA at home.

NCT ID: NCT06247644 Completed - Healthy Volunteers Clinical Trials

BD Evolve™ On-body Injector's Adherence Performance - Wear Study

Start date: February 14, 2024
Phase: N/A
Study type: Interventional

An On-body Injector is a small device, which is adhered to the skin with a sticky patch. The injector is intended to deliver a small volume of medicine from a reservoir inside the device into the skin via a small catheter. The drug delivery happens after a period of time, as programmed into the device, and afterwards the device can be removed. The purpose of this study is to evaluate how well the BD Evolve™ On-body Injector adhesive pad sticks to the skin and how the adhesive keeps the device in position when worn on the arm during normal daily activities for 28 hours. As this study only evaluates the performance of the adhesive pad of the OBI, no injection will be performed, and the device will not be filled with any fluid. The injection capability will be disabled.

NCT ID: NCT06247488 Completed - Abuse Potential Clinical Trials

Evaluation of Abuse Potential of HORIZANT Taken Alone and With Oxycodone in Healthy, Nondependent Recreational Opioid Users

Start date: January 31, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the abuse potential of gabapentin enacarbil immediate release capsules taken alone and in combination with oxycodone in healthy adult, non-dependent, recreational opioid users.

NCT ID: NCT06247462 Completed - Acute Kidney Injury Clinical Trials

Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat

Start date: June 1, 2023
Phase: Phase 1
Study type: Interventional

The goal of this study is to determine if ibuprofen prior to exercise in the heat worsens biomarkers of acute kidney injury. Participants were given 600mg of ibuprofen or placebo (corn starch) 12- and 1-hour prior to running for 1-hour in a hot environment (35°C) at moderate intensity. Urine, plasma, and serum samples were collected pre-, post-, and 1hour post-exercise to assess biomarkers of acute kidney injury. This was a double blind, randomized crossover design, so that participants completed the alternate trial (ibuprofen or placebo) at least seven days later.

NCT ID: NCT06247072 Completed - Glaucoma Clinical Trials

TRK-3 Conformance to Standards for Tonometers

Start date: February 2, 2024
Phase:
Study type: Observational

To collect measurements of a new tonometer and show conformance to standards for tonometers.

NCT ID: NCT06246812 Completed - Physical Inactivity Clinical Trials

Text Message and Competition-Based Interventions Among University Students

Start date: September 19, 2022
Phase: N/A
Study type: Interventional

The goal of this quasi-experimental study is to assess and compare the effectiveness of text message interventions and a competition-based intervention and evaluate participants' acceptability and experiences in university students. The main questions it aims to answer are: 1. What are the effects of text message interventions and competition-based interventions on university students' physical activity levels, self-efficacy, self-regulation, social support, incentive motivation, and mental well-being? 2. What are participants' perceptions regarding their experience with and acceptability of text message interventions and competition-based interventions? Participants will 1. participate in a fitness competition 2. participate in a fitness competition and receive text messages 3. enroll in control group

NCT ID: NCT06246747 Completed - Parkinson Disease Clinical Trials

The Use of Telerehabilitation to Improve Movement Outcomes for Patients With Parkinson Disease

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The goal of this pilot randomized clinical trial was to assess the feasibility of telerehabilitation (TR) for patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1. whether the recruitment to such a study will be successful and the satisfaction of both participants and clinicians will be good. 2. Clinical effectiveness of TR for patients with PD was also explored. Participants were randomized to 3 groups : 1. Clinic+TR. 2. TR-only group and 3. A usual control group. Results were compared between the groups.

NCT ID: NCT06245902 Completed - Clinical trials for Migraine With or Without Aura

An Acute Migraine Factorial Study

ANODYNE-1
Start date: February 18, 2017
Phase: Phase 2
Study type: Interventional

The study consists of a screening visit, out-patient treatment of a moderate or severe migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study Visit 2-7 days after dosing.

NCT ID: NCT06244290 Completed - Clinical trials for Dentinal Hypersensitivity

Dentinal Hypersensitivity Reduction

Start date: September 28, 2020
Phase: Phase 3
Study type: Interventional

The objective of this clinical study is to assess the efficacy of a dentifrice containing stannous fluoride (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially-available potassium-based toothpaste (Sensodyne Extra Whitening Toothpaste, GlaxoSmithKline Co., UK) and a commercially available non-desensitizing toothpaste (Colgate Cavity Protection Toothpaste, Colgate-Palmolive Company, New York, NY, USA) in the reduction of dentinal hypersensitivity over a seven (7) day period.